SEC Form 4 · accession 0001193125-26-303710
TransMedics Group, Inc. · TMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerardo Hernandez
Officer — Chief Financial Officer
Period of report
Jul 10, 2026
Accepted (ET)
Jul 14, 2026 · 9:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001756262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2026 | A | 17,246 | $0.00 | A | 31,935 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $71.23 | Jul 10, 2026 | A | 26,153 | A | — | Jul 10, 2036 | Common Stock | 26,153 | 26,153 | D |
Explanation of responses
- F1Consists of 17,246 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F2The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.